The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
Meyer
S
S
Gottschling
S
S
Gortner
L
L
D000328:Adult; D001127:Arginine Vasopressin / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001930:Brain Injuries / Q000150:complications*; D002395:Catecholamines / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004351:Drug Resistance; D006801:Humans; D008236:Lypressin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D012769:Shock / Q000188:drug therapy* / Q000209:etiology; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D002395:Catecholamines; D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin; D008236:Lypressin; D000077585:Terlipressin